MIAMI, FL / ACCESSWIRE / December 23, 2024 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the "Company", an emerging leader in age-reversal science, today announced significant findings from its co ...
Telomir Pharmaceuticals, Inc. (NASDAQ:TELO), or the “Company”, an emerging leader in age-reversal science, today announced significant findings from its copper binding studies with Telomir-1. This is ...
Gene Therapy, the Weizmann scientists present an innovative genetic treatment for Gaucher disease that has shown promising results in mice, including dramatically increasing life span and preserving ...
In September, Rakovina initiated a collaboration with Variational AI to use their Enki™ platform to discover novel kinase inhibitors. This partnership is focused on developing new therapies that could ...